机构:
Univ N Carolina, Dept Med, Div Hematol Oncol, UNC McAllister Heart Inst, Chapel Hill, NC 27599 USAUniv N Carolina, Dept Med, Div Hematol Oncol, UNC McAllister Heart Inst, Chapel Hill, NC 27599 USA
Antoniak, Silvio
[1
]
Rojas, Mauricio
论文数: 0引用数: 0
h-index: 0
机构:
Univ N Carolina, Dept Med, Div Hematol Oncol, UNC McAllister Heart Inst, Chapel Hill, NC 27599 USAUniv N Carolina, Dept Med, Div Hematol Oncol, UNC McAllister Heart Inst, Chapel Hill, NC 27599 USA
Rojas, Mauricio
[1
]
Spring, Denise
论文数: 0引用数: 0
h-index: 0
机构:
Univ Washington, Div Cardiothorac Surg, Seattle, WA 98195 USAUniv N Carolina, Dept Med, Div Hematol Oncol, UNC McAllister Heart Inst, Chapel Hill, NC 27599 USA
Spring, Denise
[2
]
Bullard, Tara A.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Rochester, Med Ctr, Aab Cardiovasc Res Inst, Rochester, NY 14642 USAUniv N Carolina, Dept Med, Div Hematol Oncol, UNC McAllister Heart Inst, Chapel Hill, NC 27599 USA
Bullard, Tara A.
[3
]
Verrier, Edward D.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Washington, Div Cardiothorac Surg, Seattle, WA 98195 USAUniv N Carolina, Dept Med, Div Hematol Oncol, UNC McAllister Heart Inst, Chapel Hill, NC 27599 USA
Verrier, Edward D.
[2
]
Blaxall, Burns C.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Rochester, Med Ctr, Aab Cardiovasc Res Inst, Rochester, NY 14642 USAUniv N Carolina, Dept Med, Div Hematol Oncol, UNC McAllister Heart Inst, Chapel Hill, NC 27599 USA
Blaxall, Burns C.
[3
]
Mackman, Nigel
论文数: 0引用数: 0
h-index: 0
机构:
Univ N Carolina, Dept Med, Div Hematol Oncol, UNC McAllister Heart Inst, Chapel Hill, NC 27599 USAUniv N Carolina, Dept Med, Div Hematol Oncol, UNC McAllister Heart Inst, Chapel Hill, NC 27599 USA
Mackman, Nigel
[1
]
Pawlinski, Rafal
论文数: 0引用数: 0
h-index: 0
机构:
Univ N Carolina, Dept Med, Div Hematol Oncol, UNC McAllister Heart Inst, Chapel Hill, NC 27599 USAUniv N Carolina, Dept Med, Div Hematol Oncol, UNC McAllister Heart Inst, Chapel Hill, NC 27599 USA
Pawlinski, Rafal
[1
]
机构:
[1] Univ N Carolina, Dept Med, Div Hematol Oncol, UNC McAllister Heart Inst, Chapel Hill, NC 27599 USA
[2] Univ Washington, Div Cardiothorac Surg, Seattle, WA 98195 USA
[3] Univ Rochester, Med Ctr, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA
Objective-To investigate the effect of protease-activated receptor (PAR) 2 deficiency on ischemia/reperfusion (I/R) injury-induced infarct size, inflammation, heart remodeling, and cardiac function. Methods and Results-PAR-2 signaling enhances inflammation in different diseases. The effect of PAR-2 deficiency in cardiac I/R injury is unknown. PAR-2(-/-) mice and wild-type littermates were subjected to 30 minutes of ischemia and up to 4 weeks of reperfusion. Infarct size, oxidative/nitrative stress, phosphorylation of mitogen-activated protein kinases, and inflammatory gene expression were assessed 2 hours after reperfusion. Changes in heart size and function were measured by echocardiography up to 4 weeks after reperfusion. Infarct size was significantly reduced in hearts of PAR-2(-/-) mice compared with wild-type littermates. In addition, oxidative/nitrative stress, phosphorylation of mitogen-activated protein kinase, and expression of proinflammatory genes were significantly attenuated in injured hearts of PAR-2(-/-) mice. Finally, PAR-2(-/-) mice were protected from postinfarction remodeling and showed less impairment in heart function compared with wild-type littermates up to 4 weeks after I/R injury. Conclusion-PAR-2 deficiency reduces myocardial infarction and heart remodeling after I/R injury. (Arterioscler Thromb Vasc Biol. 2010; 30: 2136-2142.)
机构:
Univ London Imperial Coll Sci Technol & Med, Fac Med, NHLI Div Cardiac Med, London SW7 2AZ, EnglandUniv London Imperial Coll Sci Technol & Med, Fac Med, NHLI Div Cardiac Med, London SW7 2AZ, England
机构:
Univ London Imperial Coll Sci Technol & Med, Fac Med, NHLI Div Cardiac Med, London SW7 2AZ, EnglandUniv London Imperial Coll Sci Technol & Med, Fac Med, NHLI Div Cardiac Med, London SW7 2AZ, England